Back to Journals » Drug Design, Development and Therapy » Volume 9

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

Total article views   HTML views PDF downloads Totals
20,127 Dovepress* 16,635+ 2,086 18,721
PubMed Central* 3,492 838 4,330
Totals 20,127 2,924 23,051
*Since 4 February 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar